Download PDF
Thromb Haemost 2007; 97(02): 169-170
DOI: 10.1160/TH07-01-0007
Editorial Focus
Schattauer GmbH

Retinal vein occlusion disease and platelet activation: Will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?

Suzanne Fateh-Moghadam
1   Medizinische Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum, Charite-Universitätsmedizin, Berlin, Germany
,
Meinrad Gawaz
2   Medizinische Klinik III, Universitätsklinikum Tübingen, Tübingen, Germany
› Author Affiliations
Further Information

Publication History

Received 05 January 2007

Accepted 05 January 2007

Publication Date:
25 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Shahid H, Hossain P, Amoaku WM. The management of retinal vein occlusion: is interventional ophathalmology the way forward?. Br J Ophtalmol 2006; 90: 627-639.
    CrossrefPubMedGoogle Scholar
  • 2 Cheru KC, Zegans ME. Ophtalmology Review Manual. Philadelphia, Lippincott Williams & Wilkins,. 2000: 132-146.
    Google Scholar
  • 3 Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002; 32: 308-311.
    CrossrefPubMedGoogle Scholar
  • 4 Vannas S, Tarkkanen A. Retinal vein occlusion and glaucoma: tonographic study of the incidence of glaucoma and of its prognostic significance. Br J Ophtalmol 1960; 44: 583-589.
    CrossrefPubMedGoogle Scholar
  • 5 Janssen MC, den Heijer M, Cruysberg JR. et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?. Thromb Haemost 2005; 93: 1021-1026.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Vine AK. Hyperhomocyteinemia: a risk factor for central retinal vein occlusion. Am J Ophtalmol 2000; 129: 640-644.
    CrossrefPubMedGoogle Scholar
  • 7 Leoncini G, Bruzzese D, Signorello MG. et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost 2007; 97: 218-227.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Watson PG, Gordon JL, Kok D. et al. Platelet aggregation study in ischemic retinal vascular disease. Trans Ophtalmol Soc UK 1971; 91: 223-230.
    PubMedGoogle Scholar
  • 9 Priluck IA. Impending central venal occlusion associated with increased platelet aggregability. Ann Ophtalmol 1979; 11: 79-84.
    PubMedGoogle Scholar
  • 10 Houtsmuller AJ, Vermeulen JACM, Klompe M. et al. The influence of ticlopidine on the natural course of retinal venal occlusion. Agents Actions Suppl 1984; 15: 219-229.
    PubMedGoogle Scholar
  • 11 Walsh PN, Goldberg RE, Tax RL. et al. Platelet coagulant activities and retinal vein thrombosis. Thromb Haemost 1977; 38: 399-406.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Hayreh SS. Management of central vein occlusion. Ophtalmologica 2003; 217: 167-188.
    CrossrefPubMedGoogle Scholar
  • 13 Yamamoto T, Kamei M, Yokoi N. et al. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophtalmol 2004; 138: 809-817.
    CrossrefPubMedGoogle Scholar